Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy (AVERT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2013 by University of Vermont
Sponsor:
Collaborators:
Mayo Clinic
Comprehensive Cancer Center of Wake Forest University
Norris Cotton Cancer Center
University of Massachusetts, Worcester
Information provided by (Responsible Party):
Steven Ades, University of Vermont
ClinicalTrials.gov Identifier:
NCT00970905
First received: August 25, 2009
Last updated: December 12, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)